Vascular dementia

Pathophysiology - Brain Blood Flow Blues

• Core Insult: Cerebrovascular disease (CVD) disrupts cerebral blood flow (CBF), leading to neuronal death and cognitive deficits.
• Primary Mechanisms:
  • Multi-infarct Dementia: Accumulation of multiple cortical or subcortical infarcts over time.
  • Strategic Infarct Dementia: A single, crucial infarct in an area like the thalamus or hippocampus.
  • Subcortical Ischemic Dementia: Chronic ischemia damages small vessels, causing diffuse white matter lesions (leukoaraiosis) and lacunar infarcts (e.g., Binswanger's disease).

⭐ The classic presentation is a stepwise deterioration in cognitive function, where abrupt declines are interspersed with periods of stability, reflecting subsequent ischemic events.

Clinical Features - The Stepwise Slide

• Hallmark: Abrupt, stepwise deterioration in cognitive function, often temporally related to a cerebrovascular event (e.g., stroke).
• Course: Fluctuating progression. Function declines in discrete steps with periods of stability.
• Early & Prominent Deficits:
  • Executive dysfunction (planning, decision-making).
  • Slowed processing speed.
• Associated Features:
  • Focal neurological signs (e.g., hemiparesis, visual defects).
  • Pseudobulbar affect (emotional lability).
  • Gait disturbance, unsteadiness, and frequent falls.

⭐ The "stepwise" decline is classic but not universal. A gradual, progressive course can occur with subcortical small vessel disease, often presenting with early and prominent executive dysfunction compared to the memory loss seen in Alzheimer's.

Diagnosis - Spotting the Strokes

• Clinical Picture: Hallmark is a stepwise decline in cognition, often with a clear temporal link to a stroke. Look for focal neurological deficits.
  • Hemiparesis, pronator drift
  • Visual field defects
  • Pseudobulbar affect (emotional lability)
• Neuroimaging: MRI is the preferred modality.
  • Reveals cortical/subcortical infarcts, lacunar strokes, or extensive white matter lesions (leukoaraiosis).

⭐ A "stepwise" cognitive decline, where function abruptly worsens after a vascular event and then stabilizes, is the classic historical feature distinguishing it from Alzheimer's gradual decline.

Management - Damage Control

• Primary Goal: Aggressively manage cardiovascular (CV) risk factors to prevent further ischemic insults.
  • HTN: Strict BP control (target <130/80 mmHg).
  • Diabetes: Glycemic control (target HbA1c ~7%).
  • Hyperlipidemia: High-intensity statins.
  • Antiplatelet therapy: Aspirin or clopidogrel for secondary stroke prevention.
• Cognitive Symptoms:

  ⭐ Cholinesterase inhibitors (donepezil, rivastigmine) and memantine can be considered, but have limited evidence of benefit compared to their use in Alzheimer's disease.

High-Yield Points - ⚡ Biggest Takeaways

• Stepwise cognitive decline with periods of stability, unlike the gradual decline in Alzheimer's disease.
• Caused by cerebrovascular disease, such as multiple cortical or subcortical infarcts.
• Strongly associated with vascular risk factors like hypertension, diabetes, and smoking.
• Often presents with focal neurological deficits (e.g., unilateral weakness, pronator drift).
• Neuroimaging is key, revealing evidence of prior strokes or significant white matter changes.
• Management focuses on aggressive risk factor control to prevent further ischemic events.